retatrutide efectos secundarios Estamos viendo el futuro del tratamiento de la obesidad? 👀 Retatrutide, un agonista triple de GLP-1, GIP y glucagón, acaba de presentar resultados que están llamando la atención de toda la endocrinología ¿Por qué se habla tanto

Among non-RCTs, nine studies applied MICT, three applied HIIT, one allowed participants to choose between HIIT or MICT, two combined MICT and HIIT, one focused on resistance training, and one combined MICT with resistance training

Massage gently into thinning areas

Combined culture and metagenomic analyses reveal significant shifts in the composition of the cutaneous microbiome in psoriasis

Coughlins closing line on the GLP-1 category captured the strategic logic: Were not interested in kind of me-too entries. With Entresto facing generic erosion and Leqvio soon confronting oral PCSK9 competition from Mercks Enlicitide, Novartis is staking its cardiovascular future on mechanisms that sit adjacent to not inside the metabolic pathway that everyone else is chasing